The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

Xenco Medical Founder and CEO Jason Haider speaking at the Tech in Regenerative Medicine panel at CES ... implanted with the company's regenerative biomaterial. He continued by noting that every ...

Vietnam Translational Regenerative Medicine Market Key Takeaways: ...

The CEO of Xenco Medical and the general manager of Terumo BCT discussed the future of regenerative medicine, and how we've ...

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today announced that it has closed a US$115 million ...

A Vancouver life sciences firm is printing loads of venture capital, as well as organic tissues. Aspect Biosystems Ltd. has ...

(“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that on November ...

(“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that on November ...

Now, Aspect Biosystems is kicking off 2025 with a bang: it just raised $US115 million in Series B funding, led by American ...

Caidya, a clinical research organization (CRO) based in Raleigh, has raised $165 million in private equity to support its growth.